These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1175683)

  • 21. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of short and long-lasting diabetes mellitus on mouse brain monoamines.
    Chen CC; Yang JC
    Brain Res; 1991 Jun; 552(1):175-9. PubMed ID: 1913176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of H3-norepinephrine accumulation into slices from different regions of the rat brain.
    Snyder SH; Green AI; Hendley ED
    J Pharmacol Exp Ther; 1968 Nov; 164(1):90-102. PubMed ID: 5722109
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
    Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
    Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seizure susceptibility after depletion of spinal or cerebellar noradrenaline with 6-OHDA.
    Mason ST; Corcoran ME
    Brain Res; 1979 Apr; 166(2):418-21. PubMed ID: 427596
    [No Abstract]   [Full Text] [Related]  

  • 27. Noradrenaline: kinetics of accumulation into slices from different regions of rat brain.
    Snyder SH; Green A; Hendley ED; Gfeller E
    Nature; 1968 Apr; 218(5137):174-6. PubMed ID: 4967055
    [No Abstract]   [Full Text] [Related]  

  • 28. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1972 Feb; 44(2):210-22. PubMed ID: 4148915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of the metabolite patterns of intraventricularly injected [3H]noradrenaline in rat brain regions.
    Köster G
    J Neurochem; 1986 Oct; 47(4):1132-40. PubMed ID: 3746298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 31. Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain.
    Tonge SR; Leonard BE
    Br J Pharmacol; 1973 Jun; 48(2):364P-365P. PubMed ID: 4739053
    [No Abstract]   [Full Text] [Related]  

  • 32. Regional changes in amino acid composition during anesthesia in the central nervous system of rats.
    Baxter CF
    Proc West Pharmacol Soc; 1966; 9():52-3. PubMed ID: 5958502
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective depletion of spinal noradrenaline abolishes post-decapitation convulsions.
    Roberts DC; Mason ST; Fibiger HC
    Life Sci; 1978 Dec; 23(24):2411-3. PubMed ID: 745520
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modification of the metabolism of cerebral serotonin (5-HT) induced in rats by the administration of 6-hydroxydopamine].
    Blondaux C; Juge A; Sordet F; Chouvet G; Jouvet M; Pujol JF
    Brain Res; 1973 Feb; 50(1):101-14. PubMed ID: 4690541
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fate of intracisternally administered norepinephrine-3H in the brain and spinal cord of the rabbit.
    Chalmers JP; Wurtman RJ
    J Pharmacol Exp Ther; 1971 Jul; 178(1):8-19. PubMed ID: 5087407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Regional distribution of gamma-aminobutyric acid, glutamic acid, aspartic acid, dopamine, noradrenaline and serotonin in rat brain].
    Popov N; Pohle W; Rösler V; Matthies H
    Acta Biol Med Ger; 1967; 18(6):695-702. PubMed ID: 5588993
    [No Abstract]   [Full Text] [Related]  

  • 40. Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment.
    Peterson DW; Laverty R
    Psychopharmacology (Berl); 1976 Oct; 50(1):55-60. PubMed ID: 13445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.